Atlas Trials

Testing the Effect of Raltegravir on Persistent de Novo HIV Infection in Virologic Responders to Antiretroviral Therapy

Clinical trial NCT02611895 · COMPLETED

Trial details

NCT number
NCT02611895
Sponsor
University Hospital, Montpellier
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
HIV-1 Infection
Start date
2015-03-01
Primary completion
2016-03-22
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.